[1] |
Overton E, Tobes D, Lee A. Preeclampsia diagnosis and management[J]. Best Pract Res Clin Anaesthesiol, 2022, 36(1):107-121. doi: 10.1016/j.bpa.2022.02.003.
pmid: 35659948
|
[2] |
Fishel Bartal M, Sibai BM. Eclampsia in the 21st century[J]. Am J Obstet Gynecol, 2022, 226(2S):S1237-S1253. doi: 10.1016/j.ajog. 2020.09.037.
|
[3] |
Xue Y, Yang N, Gu X, et al. Risk Prediction Model of Early-Onset Preeclampsia Based on Risk Factors and Routine Laboratory Indicators[J]. Life(Basel), 2023, 13(8):1648. doi: 10.3390/life13081648.
|
[4] |
Han L, Holland OJ, Da Silva Costa F, et al. Potential biomarkers for late-onset and term preeclampsia: A scoping review[J]. Front Physiol, 2023,14:1143543. doi: 10.3389/fphys.2023.1143543.
|
[5] |
De Kat AC, Hirst J, Woodward M, et al. Prediction models for preeclampsia: A systematic review[J]. Pregnancy Hypertens, 2019, 16:48-66. doi: 10.1016/j.preghy.2019.03.005.
pmid: 31056160
|
[6] |
Salvesen K, Abramowicz J, Ter Haar G, et al. ISUOG statement on the safe use of Doppler for fetal ultrasound examination in the first 13+6 weeks of pregnancy (updated)[J]. Ultrasound Obstet Gynecol, 2021, 57(6):1020. doi: 10.1002/uog.23610.
pmid: 34077607
|
[7] |
Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention[J]. Int J Gynaecol Obstet, 2019, 145(Suppl 1):1-33. doi: 10.1002/ijgo.12802.
|
[8] |
王聪慧, 孔祥东. 子痫前期科学防控专家共识[J]. 医药前沿, 2022, 12(23):128-132.
|
[9] |
Rocha G. Consequences of early-onset preeclampsia on neonatal morbidity and mortality[J]. Minerva Pediatr(Torino), 2023, 75(1):87-97. doi: 10.23736/S2724-5276.22.06714-3.
|
[10] |
Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens,2022, 27:148-169. doi: 10.1016/j.preghy.2021.09.008.
|
[11] |
Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction[J]. Am J Obstet Gynecol, 2022, 226(2S):S1071-S1097.e2. doi: 10.1016/j.ajog.2020.07.020.
|
[12] |
崔洪艳, 陈叙. 早发型重度子痫前期临床分析[J]. 天津医药, 2006, 34(11):809-810. doi: 10.3969/j.issn.0253-9896.2006.11.022.
|
[13] |
Veerbeek JH, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension[J]. Hypertension, 2015, 65(3):600-606. doi: 10.1161/HYPERTENSIONAHA.114.04850.
pmid: 25561694
|
[14] |
Stepan H, Hund M, Andraczek T. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome[J]. Hypertension, 2020, 75(4):918-926. doi: 10.1161/HYPERTENSIONAHA.119.13763.
pmid: 32063058
|
[15] |
Serra B, Mendoza M, Scazzocchio E, et al. A new model for screening for early-onset preeclampsia[J]. Am J Obstet Gynecol, 2020, 222(6):608.e1-e18. doi: 10.1016/j.ajog.2020.01.020.
|
[16] |
Lazdam M, de la Horra A, Diesch J, et al. Unique blood pressure characteristics in mother and offspring after early onset preeclampsia[J]. Hypertension, 2012, 60(5):1338-1345. doi: 10.1161/HYPERTENSIONAHA.112.198366.
pmid: 23045462
|
[17] |
O′Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation[J]. Am J Obstet Gynecol, 2016, 214(1):103.e1-e12. doi: 10.1016/j.ajog.2015.08.034.
|
[18] |
Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, et al. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia[J]. Ultrasound Obstet Gynecol, 2014, 43(5):525-532. doi: 10.1002/uog.13224.
pmid: 24185845
|
[19] |
Kang Q, Li W, Xiao J, et al. Identification of potential crucial genes associated with early-onset preeclampsia via bioinformatic analysis[J]. Pregnancy Hypertens, 2021, 24:27-36. doi: 10.1016/j.preghy.2021.02.007.
pmid: 33640831
|
[20] |
Mach P, Nolte-Boenigk L, Droste L, et al. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia[J]. Am J Reprod Immunol, 2018, 80(3):e12988. doi: 10.1111/aji.12988.
|
[21] |
Yun L, Yu X, Xu R. Uric acid/superoxide dismutase can predict progression of gestational hypertension to preeclampsia[J]. Front Cardiovasc Med, 2023,10:1148376. doi: 10.3389/fcvm.2023.1148376.
|
[22] |
Ranjbar A, Montazeri F, Ghamsari SR, et al. Machine learning models for predicting preeclampsia: a systematic review[J]. BMC Pregnancy Childbirth, 2024, 24(1):6. doi: 10.1186/s12884-023-06220-1.
|
[23] |
Mendoza M, Tur H, Garcia-Manau P, et al. Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler[J]. J Gynecol Obstet Hum Reprod, 2021, 50(1):101827. doi: 10.1016/j.jogoh.2020.101827.
|
[24] |
Zhang Y, Sylvester KG, Jin B, et al. Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy[J]. Metabolites, 2023, 13(6):715. doi: 10.3390/metabo13060715.
|